| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041937 |
| Receipt No. | R000047866 |
| Scientific Title | Survey of major adverse events in osteoporotic patients using eldecalcitol and bisphosphonates |
| Date of disclosure of the study information | 2020/10/01 |
| Last modified on | 2022/02/16 (Ver. 4) |
| Basic information | ||
| Public title | Survey of major adverse events in osteoporotic patients using eldecalcitol and bisphosphonates | |
| Acronym | Survey of major adverse events in osteoporotic patients using eldecalcitol and bisphosphonates | |
| Scientific Title | Survey of major adverse events in osteoporotic patients using eldecalcitol and bisphosphonates | |
| Scientific Title:Acronym | Survey of major adverse events in osteoporotic patients using eldecalcitol and bisphosphonates | |
| Region |
|
|
| Condition | |||||
| Condition | osteoporosis | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Survey of major adverse events in osteoporotic patients using eldecalcitol and bisphosphonates |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Number of Hypercalcemia, acute kidney injury, urinary calculus, osteonecrosis of jaw, atypical femoral fracture |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with osteoporosis who started eldecalcitol or bisphosphonate | |||
| Key exclusion criteria | Patients whose gender and age information on the first prescription date cannot be confirmed | |||
| Target sample size | 3000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | CHUGAI PHARMACEUTICAL CO.,LTD. | ||||||
| Division name | Medical Science Dept. | ||||||
| Zip code | 103-8324 | ||||||
| Address | 1-1 Nihonbashi-Muromachi 2-Chome,Chuo-Ku Tokyo | ||||||
| TEL | 03-3273-0866 | ||||||
| kondosts@chugai-pharm.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | CHUGAI PHARMACEUTICAL CO.,LTD. | ||||||
| Division name | Medical Science Dept. | ||||||
| Zip code | 103-8324 | ||||||
| Address | 1-1 Nihonbashi-Muromachi 2-Chome,Chuo-Ku Tokyo | ||||||
| TEL | 03-3273-0866 | ||||||
| Homepage URL | |||||||
| kondosts@chugai-pharm.co.jp | |||||||
| Sponsor | |
| Institute | CHUGAI PHARMACEUTICAL CO.,LTD.
Medical Science Dept. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self-funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Non-Profit Organization MINS Institutional Review Board |
| Address | 1-15-14, Dogenzaka, Shibuya, Tokyo, Japan |
| Tel | 03-6416-1868 |
| npo-mins@j-irb.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://pubmed.ncbi.nlm.nih.gov/35041084/ | ||||||
| Number of participants that the trial has enrolled | 132832 | ||||||
| Results | |||||||
| Results date posted | |||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Database research |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047866 |